Refractory solid tumor
Showing 1 - 25 of >10,000
Solid Tumor, Adult, Refractory Cancer Trial (GV20-0251)
Not yet recruiting
- Solid Tumor, Adult
- Refractory Cancer
- (no location specified)
Dec 21, 2022
Refractory Solid Tumor Trial in Xiamen (177Lu-DOTA-EB-FAPI radionuclide therapy)
Recruiting
- Refractory Solid Tumor
- 177Lu-DOTA-EB-FAPI radionuclide therapy
-
Xiamen, Fujian, ChinaThe First Affiliated Hospital of Xiamen University
Jul 26, 2023
Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)
Recruiting
- Refractory Solid Tumor
- +4 more
- Atezolizumab
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 4, 2022
DOTr/DOTa Algorithm Guidance for Refractory Solid Tumors
Recruiting
- Solid Tumor
- Individuation
- Recommended treatment plan
-
Tianjin, Tianjin, ChinaTianjin Medical Unversity Second Hospital
Aug 23, 2023
Solid Tumors, Adult Trial (tumor treatment vaccine injection)
Not yet recruiting
- Solid Tumors, Adult
- tumor treatment vaccine injection
- (no location specified)
Feb 16, 2023
Pathologically Confirmed Cancer Refractory to Conventional Therapy, Refractory Cancer, Metastatic Cancer Trial in Santa Monica
Not yet recruiting
- Pathologically Confirmed Cancer Refractory to Conventional Therapy
- +7 more
- SNK02
-
Santa Monica, CaliforniaSarcoma Oncology Center
Aug 10, 2023
Relapsed or Refractory Lymphomas, Advanced Solid Tumor Trial in Los Alamitos (LP-284)
Not yet recruiting
- Relapsed or Refractory Lymphomas
- Advanced Solid Tumor
-
Los Alamitos, CaliforniaCancer and Blood Specialty Clinic
Nov 9, 2023
Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)
Not yet recruiting
- Advanced Solid Tumor
- Refractory Non-Hodgkin Lymphoma
- (no location specified)
May 28, 2023
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Thymalfasin
- +3 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Mar 29, 2023
Solid Tumor Trial in Taichung (HLA-G-CAR.BiTE allogeneic ?d T cells)
Not yet recruiting
- Solid Tumor
- HLA-G-CAR.BiTE allogeneic γδ T cells
-
Taichung, Non-US, TaiwanChina Medical University Hospital
Nov 27, 2023
Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic
Not yet recruiting
- Advanced Solid Tumor
- +4 more
- Cadonilimab
- Stereotactic body radiotherapy
-
Peking, Beijing, ChinaDepartment of radiation oncology, Peking University Third Hospit
Jun 20, 2023
Relapsed Solid Tumor, Refractory Cancer, Solid Tumor, Adult Trial (STI-3258)
Withdrawn
- Relapsed Solid Neoplasm
- +2 more
- STI-3258
- (no location specified)
Jan 24, 2023
Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory, Advanced Solid Tumor Trial (TR115)
Not yet recruiting
- Non-Hodgkin's Lymphoma, Relapsed
- +2 more
- (no location specified)
Dec 6, 2022
Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer Trial (ADU-1805, Pembrolizumab)
Not yet recruiting
- Solid Tumor, Adult
- +2 more
- (no location specified)
May 3, 2023
Hepatobiliary, Pancreatic and Other Gastrointestinal Carcinoma (Non-stomach, Non-esophagi) Trial in Shanghai (Capecitabine,
Recruiting
- Hepatobiliary, Pancreatic and Other Gastrointestinal Carcinoma (Non-stomach, Non-esophagi)
- Capecitabine, Camrelizumab
-
Shanghai, ChinaDepartment of Oncology, Ruijin Hospital
Sep 16, 2021
TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors Trial in Nanning (KSX01-TCRT injection)
Recruiting
- TCR-T Cells
- +2 more
- KSX01-TCRT injection
-
Nanning, Guangxi Zhuang Autonomous Region, ChinaThe first affiliated hospital of Guang Xi medical university
Mar 31, 2023
Melanoma, Lymphoma, Solid Tumor Trial in Worldwide (Pembrolizumab)
Recruiting
- Melanoma
- +4 more
- Pembrolizumab
-
Aurora, Colorado
- +18 more
Jan 5, 2023